LAB · ISSUER CIK 1162194
STANDARD BIOTOOLS INC.
Between Aug 1, 2026 and Oct 29, 2026, 3 STANDARD BIOTOOLS INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 202617:06 | Aug 20, 2026 | LAB | SVP & Chief Business Officer | F · Tax | $0.67 | −25,729 | 1,480,823 | -2% | $17K | ||
| Aug 24, 202617:05 | Aug 20, 2026 | LAB | Chief Financial Officer | F · Tax | $0.67 | −28,195 | 2,534,859 | -1% | $19K | ||
| Aug 24, 202617:04 | Aug 20, 2026 | LAB | President & CEO, Director | F · Tax | $0.67 | −97,627 | 6,137,704 | -2% | $66K | ||
| Aug 4, 202618:01 | Aug 3, 2026 | LAB | President & CEO, Director | F · Tax | $0.87 | −362,625 | 6,235,331 | -5% | $315K |